Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.15 USD | -1.45% | +0.55% | +22.82% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | -1.45% | ||
1 week | +0.55% | ||
Current month | -0.54% | ||
3 months | +11.72% | ||
6 months | +14.38% | ||
Current year | +22.82% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 9.15 | -1.45% | 13,748 |
24-06-04 | 9.285 | +0.38% | 903 |
24-06-03 | 9.25 | +0.54% | 3,577 |
24-05-31 | 9.2 | 0.00% | 1,354 |
24-05-30 | 9.2 | +1.10% | 10,614 |
Delayed Quote Nasdaq, June 05, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+22.82% | 16.67M | |
+55.70% | 59.34B | |
+43.00% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- TLIS Stock